Skip to main content
SIU 2026 Main banner
 
Presentation Icons
Surgery Day
Surgery Day
Bench to Bedside
Bench to Bedside
SIU@U
SIU@U
    Session Type: Bench-to-Bedside

    8th Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting - PROSTATE CANCER

    Friday, November 13, 2026
    14:35 - 16:15 CET

    Bench to Bedside SIU@U

      Moderator(s)

    • Silvia Secco

      Urologist - Consultant
      Niguarda Hospital, Italy

    The rapidly evolving landscape of GU cancers presents significant challenges for specialists across urology, medical oncology, and radiation oncology. As new data emerge, clinicians are required to stay current with the latest developments to ensure the highest standard of care for their patients.

    Join the prestigious B2B Scientific Programme Committee and global thought leaders to stay current with the latest advances and evidence-based practices in GU cancers. In this all-day programme, the multidisciplinary faculty will review updates on diagnosis and treatment of prostate, bladder, and kidney cancers, discuss applications of new therapeutic strategies and surgical skills into clinical practice, and provide guidance for improving patient-centered care.

    Learning Objectives:

    At the end of this session, attendees should be able to:
    • Evaluate the benefits, risks, and limitations of various treatment options across the management continuum in prostate cancer, bladder cancer, and kidney cancer.
    • Recognize the role of imaging and genetic markers in guiding treatment decision-making.
    • Analyze the efficacy and safety of emerging therapeutic approaches for the management of GU cancers based on current clinical data.
    • Recall strategies to identify, manage, and mitigate adverse events related to systemic treatment.
    • Discuss the importance of personalized medicine, based on treatment costs and patient preference, while minimizing toxicity and maximizing efficacy.

    Presentations:

    • 14:35 - 14:50 CET
      Risk-Adapted Prostate Cancer Screening

      Speaker: Peter Albers – Medical Faculty, Heinrich-Heine University Düsseldorf

    • 14:50 CET
      Debate: Micro-Ultrasound Can Replace MRI-Guided Prostate Biopsy

      Moderator: Silvia Secco – Niguarda Hospital

    • 14:50 - 14:58 CET
      Pros

      Speaker: Rafael Sanchez-Salas – McGill University

    • 14:58 - 15:06 CET
      Cons

      Speaker: Rossella Nicoletti – University of Palermo

    • 15:06 - 15:15 CET
      Discussion and Q&A

      Moderator: Silvia Secco – Niguarda Hospital

      Speaker: Rossella Nicoletti – University of Palermo

      Speaker: Rafael Sanchez-Salas – McGill University

    • 15:15 - 15:30 CET
      Innovative Use of PSMA-Radioguided Surgery to Identify a Novel Immune Therapeutic Strategy for Prostate Cancer

      Speaker: Elio Mazzone

    • 15:30 - 15:45 CET
      Role of Radiotherapy in Prostate Cancer Management
    • 15:45 - 16:15 CET
      Case-Based Discussion: Treatment Decision-Making in Metastatic Castrate-Sensitive Prostate Cancer - A Multidisciplinary Tumour Board

      Moderator: Elio Mazzone

      Panelist: Peter Albers – Medical Faculty, Heinrich-Heine University Düsseldorf

      Panelist: Rossella Nicoletti – University of Palermo

      Panelist: Lorenzo Antonuzzo – University of Florence